Celldex Therapeutics Inc (CLDX)
$30.10 +0.70% Close Oct 30, 2026 Live
Celldex Therapeutics stock today
Celldex Therapeutics closed at $30.10 on October 30, 2026, up 0.70% on the day. Over the past year it returned +15.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.36 billion.
$30.00$40.00
NovJan 2026MarMayJulSep
| Period | CLDX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -7.1% | -0.9% |
| 3 months | -21.8% | +2.1% |
| Year to date | +10.8% | +11.7% |
| 1 year | +15.8% | +12.4% |
| 3 years | +32.6% | +88.5% |
| 5 years | -29.2% | +76.0% |
Key statistics
- Market value
- $2.36B
- 52-week range
- $22.58 to $44.87
- Next report
- Nov 9, 2026 (estimated)
About Celldex Therapeutics
Develops immunotherapy and oncology drugs in clinical development.
Sector: Health Care
More on Celldex Therapeutics
- Financials: revenue, earnings and segmentsRevenue -78% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $631.03 today
No forecast, no recommendation. This page describes Celldex Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.